COMING SOON - PICO ATLAS
COMING SOON - PICO ATLAS
PICO ATLAS
A start-to-finish tool in determining PICOs for the EU HTA process across 27 countries.
>provides an immediate overview of the PICO landscape in any oncology indication
Population Segments
Appropriate Comparators
Relevant Outcomes
>based on Health technology Assessment (HTAs) and registry data from more than 20 countries
1’000+
HEALTH TECHNOLOGY ASSESSMENTS
2’000+
UNIQUE PICOs
20+
COUNTRIES
REPLACE MONTHS OF CONSULTING PROJECTS WITH ONLY MINUTES OF PICO ATLAS
From HTA report aggregation, translation, to data extraction and eventually analysis. Everything that used to take months and tens of thousands of euros through consulting projects, PICO ATLAS now does it in minutes at a fraction of the cost.
AGENTIC AI SEMINARS
Get your team up to speed with the latest Agentic AI tools. With bespoke seminars for every pharma function.
“A fascinating first exposure to the world of agentic AI!“
-INCYTE participant-
turning SCATTERED DATA into concrete knowledge
ABOUT NEMETON
“Currently, European HTA data unfortunately is a very disconnected archipelago of information, lacking the infrastructure needed in Market Access for a panoramic view. I built Nemeton to harness natural language processors and turn scattered data into concrete knowledge.
PICO ATLAS is the first tool to embrace the full complexity of the various data points needed for a thorough assessment of EU HTA PICO possibilities.
I look forward to developing more tools that will bridge the gaps between data and pharma companies.”
Nemeton operates from Antwerp, Belgium.
CONTACT US
AN AI POWERED SOLUTION FOR MARKET ACCESS
FREQUENTLY ASKED QUESTIONS
-
The BETA version of PICO ATLAS will be released in February 2026. You can reach out through the contact form to gain access.
-
Any pharma professional who wants to improve productivity with agentic AI.
-
Yes. Plan a seminar call to evaluate your needs